Literature DB >> 11358836

Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas.

P Heimann1, H El Housni, G Ogur, M A Weterman, E M Petty, G Vassart.   

Abstract

A subset of childhood and young adult renal cell carcinomas displays a recurrent translocation t(X;17)(p11;q25) as the sole cytogenetic abnormality. In two young girls, we demonstrate that this translocation results in the fusion of a novel gene, designated RCC17, at chromosome 17q25, to the transcription factor TFE3 located on the Xp11 chromosomal region. In both cases, the t(X;17) fuses the NH(2)-terminal region of RCC17 to the COOH-terminal part of TFE3 including the basic helix-loop-helix DNA-binding domain and the leucine zipper dimerization domain. The reciprocal fusion transcript TFE3/RCC17 is also expressed. RCC17 encodes a putative protein of 553 amino acids. It is ubiquitously expressed in normal adult tissues. No significant similarity was found with other fusion partners of TFE3 or with any relevant functional protein domains, precluding informed speculation about the normal function of this gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358836

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor.

Authors:  Paloma H Giangrande; Timothy C Hallstrom; Chainarong Tunyaplin; Kathryn Calame; Joseph R Nevins
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

2.  Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains.

Authors:  Roland P Kuiper; Marga Schepens; José Thijssen; Eric F P M Schoenmakers; Ad Geurts van Kessel
Journal:  Nucleic Acids Res       Date:  2004-04-26       Impact factor: 16.971

3.  Translocation renal cell carcinomas in adults: a single-institution experience.

Authors:  Minghao Zhong; Patricia De Angelo; Lisa Osborne; Alberto E Paniz-Mondolfi; Matthew Geller; Youfeng Yang; W Marston Linehan; Maria J Merino; Carlos Cordon-Cardo; Dongming Cai
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

4.  Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.

Authors:  Erez Feige; Satoru Yokoyama; Carmit Levy; Mehdi Khaled; Vivien Igras; Richard J Lin; Stephen Lee; Hans R Widlund; Scott R Granter; Andrew L Kung; David E Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

5.  Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma.

Authors:  Minghao Zhong; Patricia De Angelo; Lisa Osborne; Megan Keane-Tarchichi; Michael Goldfischer; Lisa Edelmann; Youfeng Yang; W Marston Linehan; Maria J Merino; Seena Aisner; Meera Hameed
Journal:  Am J Surg Pathol       Date:  2010-06       Impact factor: 6.394

6.  Usefulness of a break-apart FISH assay in the diagnosis of Xp11.2 translocation renal cell carcinoma.

Authors:  Soo Hee Kim; Yoomi Choi; Hae Yeon Jeong; Kyoungbun Lee; Ji Youn Chae; Kyung Chul Moon
Journal:  Virchows Arch       Date:  2011-07-20       Impact factor: 4.064

7.  Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation.

Authors:  Ian J Davis; Bae-Li Hsi; Jason D Arroyo; Sara O Vargas; Y Albert Yeh; Gabriela Motyckova; Patricia Valencia; Antonio R Perez-Atayde; Pedram Argani; Marc Ladanyi; Jonathan A Fletcher; David E Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

8.  Expression of MET in alveolar soft part sarcoma.

Authors:  Hyun Jung Jun; Jeeyun Lee; Do Hyoung Lim; Joon Oh Park; Geunghwan Ahn; Sung Wook Seo; Ki-Sun Sung; Do Hoon Lim; Keon Hee Yoo; Yoon-La Choi
Journal:  Med Oncol       Date:  2009-05-27       Impact factor: 3.064

9.  The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma.

Authors:  Renaud Grépin; Damien Ambrosetti; Alexandre Marsaud; Lauris Gastaud; Jean Amiel; Florence Pedeutour; Gilles Pagès
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

10.  Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.

Authors:  Dinesh Pradhan; Somak Roy; Gabriela Quiroga-Garza; Kathleen Cieply; Alyssa L Mahaffey; Sheldon Bastacky; Rajiv Dhir; Anil V Parwani
Journal:  Diagn Pathol       Date:  2015-09-29       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.